Hyaluronic acid injections may be considered for selected knee osteoarthritis or arthritis-related knee pain when clinically appropriate.
Hyaluronic acid injections can help lubricate and cushion arthritic joints, reducing pain and improving movement. Dr. Siefferman explains how this treatment is used in the knees, jaw, shoulders, hips, and other joints affected by wear and tear.
Our team organizes conditions and treatments into related zones of expertise to make it easier to explore the care paths most relevant to your symptoms and goals.
Use the zone tags above to browse dedicated pages for each focus area, including services, providers, and what to expect during treatment.
Hi, I’m Dr. Jason Siefferman, an interventional pain specialist and medical director at Manhattan Pain Medicine. Hyaluronic acid used in facial fillers is also used in joints. It is FDA approved for the knee, but we will also use it in a variety of other joints because it serves the same purpose. It is both a cushion and a lubricant.
If there’s a joint where there is some arthritic change, meaning the bony contact points have become a little worn or irregular, putting hyaluronic acid in that space can lubricate it, so there’s not so much of a bone on bone effect. There’s a little bit more cushion to the joint. It lasts about 6 months and generally triggers no inflammatory response. So, it’s very well tolerated. We will use it in the temporomandibular joint, in the shoulders, hips, ankles, really anywhere there’s a joint that contacts that may benefit from some cushion.
Hyaluronic acid viscosupplementation is an injection treatment most commonly used for selected patients with knee osteoarthritis or arthritis-related knee pain. These injections, sometimes called gel injections, are intended to supplement the joint fluid and may help improve lubrication and shock absorption in the knee.
At Manhattan Pain Medicine, hyaluronic acid injections NYC care begins with diagnosis-first evaluation. The goal is to determine whether the patient’s knee pain is related to osteoarthritis, patellofemoral mechanics, inflammation, instability, hip or pelvic mechanics, or another pain source before recommending treatment.
MPM specialists evaluate whether hyaluronic acid viscosupplementation may be appropriate by first clarifying the source of knee pain. Knee symptoms may come from osteoarthritis, patellofemoral mechanics, inflammatory arthritis, meniscal symptoms, ligament instability, hypermobility, hip mechanics, pelvic mechanics, tendons, bursae, or referred pain.
MPM reviews the diagnosis, imaging, physical exam, prior injections, medication history, physical therapy response, activity limitations, and patient goals. This helps determine whether hyaluronic acid injections, steroid injections, PRP, prolotherapy, BMAC, bracing, rehabilitation, or orthopedic referral may be the better fit.
Jason W. Siefferman, MD
Medical Director | Interventional Pain Management | Headache Medicine
Nino Mikaberidze, MD
Director of Rheumatology & Internal Medicine
Luis Aranguren, MD
Interventional Pain Management
Tayyaba Ahmed, DO
Physical Medicine & Rehabilitation | Pelvic Pain
Adam Rosenberg, PA-C
Board-Certified Physician Assistant
Jordan Shankle, PA-C
Board-Certified Physician Assistant
Hyaluronic acid viscosupplementation is most commonly considered for knee osteoarthritis pain when conservative treatments have not provided enough relief. Patients may explore knee gel injections after trying physical therapy, oral pain relievers, activity modification, bracing, weight management strategies, or other non-surgical options.
MPM does not present viscosupplementation as cartilage restoration, arthritis reversal, or a guaranteed way to avoid knee replacement. Evidence and guideline recommendations are mixed, and patient selection matters. Some patients may experience symptom improvement, while others may have limited or no benefit. MPM evaluates the knee joint, arthritis severity, mechanical contributors, prior treatment response, hypermobility or joint instability, patellofemoral symptoms, and pelvic or hip mechanics before recommending treatment. The decision may also involve comparing hyaluronic acid with steroid injections, PRP, prolotherapy, BMAC, rehabilitation, and surgical consultation when appropriate.
Hyaluronic acid viscosupplementation fits within MPM’s Musculoskeletal issues and Hypermobility expertise. For musculoskeletal pain, knee arthritis may overlap with patellofemoral symptoms, altered gait, hip mechanics, pelvic mechanics, tendon overload, or reduced walking tolerance. For patients with hypermobility or joint instability, knee pain may reflect both joint surface irritation and abnormal load across the joint.
MPM evaluates these overlapping factors before recommending treatment. Hyaluronic acid injections may be considered for selected knee osteoarthritis patients, but they do not cure arthritis, restore cartilage, correct instability, or replace rehabilitation. The broader plan may include strengthening, bracing, activity modification, medication management, steroid injections, regenerative medicine, or orthopedic referral when appropriate.
Before hyaluronic acid viscosupplementation, MPM reviews the diagnosis, knee imaging, arthritis severity, prior treatments, medication use, allergies, insurance requirements, risks, alternatives, and expected timeline. The injection is directed into the knee joint. Ultrasound guidance may be used when appropriate to support more precise placement.
Patients may feel pressure, brief discomfort, or soreness during or after the injection. Some people are able to walk after treatment, though temporary activity modification may be recommended. Relief, if it occurs, may take time and may vary by patient. Some treatment plans involve one injection, while others involve a series, depending on the product, diagnosis, insurance requirements, and clinical plan. If symptoms do not improve, MPM reassesses whether the pain source is knee osteoarthritis or whether another contributor is involved.
I cannot say enough good things about Manhattan Pain Medicine. From the moment I walked in, I felt truly cared for and taken seriously. Dr. Nino Mikaberidze, Director of Rheumatology, is exceptional — knowledgeable, compassionate, and incredibly thorough. She takes the time to listen, explains every...
The best care I've received as a chronic pain patient. I traveled from out of state to visit Manhattan Pain Medicine because I could not find knowledgeable doctors in my hometown for my hypermobility, and Ehlers-Danlos syndrome symptoms and comorbidities. Let me tell you, it was worth every travel e...
I was injured in a bicycle accident over 8 years ago. I’ve suffered throughout the years since my accident with nothing seeming to work. PT, Yoga, lifestyle changes, NOTHNG! I finally made an appointment with Dr Kane and I’m feeling an improvement in my life. I no longer stay up all night in pain, a...
One of the best experiences, if not the best, I have ever had at the doctor’s office. From the front desk to the nurses to the PA assisting the doctor this was a great experience. Dr.Nino actually listened to me and came up with a game plan. Would recommend this practice to as many people as I could...
I have very unique & severe nerve pain from CRPS which has no known specific cure. Dr. Siefferman has a huge tool box, far greater than the other 23 Drs. I have seen. He saved me from jumping off a bridge and continues to help me with both treatments and advice. Dr. S. is in a different league!
After two years of searching and feeling lost and let down, I finally found real help at Manhattan Pain Medicine. With Dr. Siefferman, Adam Rosenberg, Dr. Mikaberidze, and the whole team, I feel heard, supported and understood. Every symptom is being considered and I’m finally getting answers with m...
Why is Dr Dr. Tayyaba Ahmed one of the top pevic Floor specialists - 1- She wants to know a full history of what led the patient to get to this point. 2 - She listens intensley to the patient 3- She does not rush you 4- Extremely skilled at giving pelvic floor injections 5- I thank my luck stars she...
The staff was friendly and helpful. Dr. Siefferman was thoughtful, listened, asked questions and proposed simple safe ways to come to further conclusions regarding my pain and discomfort. The office staff including Dr. Siefferman is responsive even after the initial in-person visit. Very pleased.
Dr. Siefferman is a brilliant provider. While my pain is still a work in progress, Dr Siefferman always gives me options and explains his reasoning behind things. He listens to my feedback and concerns. I never feel rushed; and am grateful he works to meet me where I am. I highly recommend him.
What a great find! They listen to me, I listen to them and the diagnosis is made and a plan developed to develop an approach to treat all of my chronic pain. I wish I could have discovered this type of treatment sooner. This doctor and group give me hope.
Hyaluronic acid viscosupplementation is an injection treatment most commonly used for selected patients with knee osteoarthritis or arthritis-related knee pain. Hyaluronic acid is injected into the knee joint with the goal of improving joint lubrication and shock absorption. It is sometimes called a gel injection. Viscosupplementation does not cure arthritis, restore cartilage, or reverse osteoarthritis. At MPM, hyaluronic acid injections NYC care begins with diagnosis-first evaluation to determine whether the knee joint is the right treatment target.
Yes, hyaluronic acid injections are often called gel injections because the medication has a gel-like quality. These injections are used most commonly for knee osteoarthritis pain and are intended to supplement the fluid inside the joint. The terms viscosupplementation, hyaluronic acid injections, and knee gel injections are often used together. MPM helps patients understand whether this treatment fits their diagnosis, prior treatment response, insurance requirements, and overall knee care plan.
Hyaluronic acid injections are intended to improve lubrication and shock absorption inside the knee joint. For selected patients with knee osteoarthritis, this may help reduce pain and improve function. The response varies and is not guaranteed. Hyaluronic acid does not rebuild cartilage or correct all causes of knee pain. MPM evaluates whether symptoms are likely related to osteoarthritis or whether patellofemoral mechanics, instability, inflammation, tendon pain, hip mechanics, pelvic mechanics, or another source is contributing.
Hyaluronic acid injections may be considered for selected patients with knee osteoarthritis when other conservative treatments have not provided enough relief. Some patients may experience pain or function improvement, while others may not respond. Guideline recommendations are mixed, so patient selection and shared decision-making are important. MPM reviews arthritis severity, imaging, prior treatment response, activity goals, safety factors, and alternative options before recommending viscosupplementation for knee osteoarthritis.
Viscosupplementation may be considered only when patellofemoral symptoms are connected to knee osteoarthritis or joint surface irritation that fits the treatment rationale. Patellofemoral knee pain can also be driven by tracking mechanics, hip weakness, pelvic mechanics, tendon irritation, instability, overuse, or muscle imbalance. MPM evaluates the full knee mechanics before recommending hyaluronic acid injections. Rehabilitation, bracing, activity modification, or other injection options may be more appropriate depending on the diagnosis.
Steroid injections are used to reduce inflammation and may work more quickly for selected inflammatory pain patterns. Hyaluronic acid injections are intended to improve joint lubrication and shock absorption in selected knee osteoarthritis patients. The expected timeline, risks, benefits, and repeat-treatment considerations differ. Neither option is best for every patient. MPM evaluates whether knee pain is inflammatory, mechanical, arthritis-related, instability-related, or mixed before recommending hyaluronic acid, steroid injection, or another pathway.
Hyaluronic acid is a medication injected into the knee joint to supplement joint fluid in selected osteoarthritis cases. PRP is prepared from the patient’s own blood and processed to concentrate platelets before injection into a selected target. PRP is considered a regenerative medicine approach, while hyaluronic acid is a viscosupplement. Evidence, cost, insurance coverage, recovery expectations, and candidacy differ. MPM helps compare these options based on diagnosis, arthritis severity, and patient goals.
Hyaluronic acid viscosupplementation, prolotherapy, and BMAC are different treatments. Hyaluronic acid is generally used for selected knee osteoarthritis pain. Prolotherapy uses an injected solution to stimulate a local tissue response in selected ligament, tendon, or joint-related targets. BMAC uses concentrated bone marrow aspirate in selected orthobiologic contexts. MPM evaluates whether knee pain is arthritis-related, instability-related, inflammatory, mechanical, or mixed before recommending one approach over another.
The number of injections depends on the hyaluronic acid product, diagnosis, insurance requirements, and treatment plan. Some products are given as one injection, while others are given as a series over several weeks. MPM reviews the specific plan before treatment. The number of injections should not be determined by product marketing alone. It should be based on the patient’s knee diagnosis, safety profile, prior treatment response, and care goals.
Hyaluronic acid injections may take time to work. Some patients notice improvement within several weeks, while others have limited or no benefit. Relief is not usually immediate in the same way that local anesthetic may be. The timeline varies by patient, arthritis severity, product used, activity level, and whether the knee joint is the true pain source. MPM monitors response and reassesses the plan if symptoms persist.
Relief from hyaluronic acid injections varies. Some patients may experience symptom improvement for months, while others may have shorter benefit or no meaningful improvement. The duration depends on arthritis severity, activity demands, knee mechanics, prior treatment response, and whether other pain contributors are present. Hyaluronic acid injections do not cure osteoarthritis or prevent future treatment needs. MPM uses the response to guide next steps in care.
Hyaluronic acid injections are FDA-approved for knee osteoarthritis, but they are not broadly approved for every joint or every type of musculoskeletal pain. They should not be presented as a general joint pain treatment or a cartilage restoration procedure. MPM evaluates whether the patient’s diagnosis fits the treatment and whether alternative options may be more appropriate. This is especially important when pain involves the hip, shoulder, spine, hypermobility, or inflammatory disease.
Insurance coverage varies by plan, diagnosis, product, prior treatment history, and authorization requirements. Some insurers require documentation of knee osteoarthritis and prior conservative treatment before covering viscosupplementation. Others may limit coverage or require prior authorization. MPM can help clarify the clinical rationale for treatment, but coverage decisions depend on the payer and specific policy. Patients should confirm benefits and out-of-pocket costs before treatment.
Risks may include injection-site pain, swelling, warmth, stiffness, bruising, bleeding, infection, allergic reaction, post-injection flare, incomplete relief, temporary relief only, or persistent symptoms. Some patients may have increased soreness for a short period after treatment. Serious complications are uncommon but require prompt evaluation. Patients should seek urgent care for fever, spreading redness, severe swelling, hot swollen joint, sudden inability to bear weight, calf swelling, chest pain, shortness of breath, or rapidly worsening symptoms.
Hyaluronic acid injections may not be appropriate when knee pain is not primarily related to osteoarthritis, when infection is suspected, when there is a severe acute injury, when another joint or structure is the main pain source, or when surgery should be considered. They are also not a substitute for physical therapy, bracing, weight management strategies, medication management, or orthopedic evaluation when those are needed. MPM evaluates candidacy before recommending treatment.
Before care begins, our team helps patients understand the practical side of treatment, including insurance verification, out-of-network benefits, cost-share estimates, self-pay options, and billing questions. We believe patients should have as much clarity as possible before moving forward.
If you are considering hyaluronic acid injections in NYC for knee osteoarthritis, knee arthritis pain, patellofemoral symptoms, or persistent knee pain, MPM can help determine whether viscosupplementation may be appropriate. Your evaluation will consider your diagnosis, imaging, arthritis severity, mechanics, prior treatments, insurance requirements, safety factors, and care goals before any recommendation is made.
Jason W. Siefferman, MD
Jason W. Siefferman, MD
MPM
Hyaluronic acid viscosupplementation is an injection treatment used most commonly for selected patients with knee osteoarthritis or arthritis-related knee pain. These injections are sometimes called gel injections. The goal is to supplement the fluid inside the knee joint and improve lubrication and shock absorption.
At Manhattan Pain Medicine (MPM), hyaluronic acid injections NYC care begins with diagnosis-first evaluation. The goal is to determine whether knee osteoarthritis is the likely pain source and whether viscosupplementation fits the patient’s symptoms, imaging, prior treatment response, safety profile, and care goals.
Hyaluronic acid is a substance naturally present in joint fluid. In osteoarthritis, joint fluid quality and joint mechanics may change. Viscosupplementation places hyaluronic acid into the knee joint with the goal of improving the joint environment. For selected patients, this may help reduce pain and improve walking tolerance or function.
Hyaluronic acid injections do not restore cartilage, reverse arthritis, or correct all causes of knee pain. Results vary, and some patients do not experience meaningful relief.
Hyaluronic acid injections are most commonly considered for knee osteoarthritis when conservative treatment has not provided enough relief. Patients may have already tried physical therapy, oral pain relievers, activity modification, bracing, steroid injections, or other non-surgical treatments.
MPM evaluates arthritis severity, imaging, swelling, stiffness, mechanical symptoms, walking tolerance, prior injection response, and patient goals. The team also considers whether knee pain may be influenced by patellofemoral mechanics, hip weakness, pelvic mechanics, hypermobility, joint instability, inflammation, tendons, or referred pain.
Steroid injections and hyaluronic acid injections have different purposes. Steroid injections are anti-inflammatory and may be helpful when inflammation is a major driver. They may work more quickly for some patients but may not be appropriate for repeated use in every joint or situation.
Hyaluronic acid injections are designed to supplement joint fluid and may have a different onset and duration pattern. They may be considered when steroid injections did not last, when steroid risk is a concern, or when the clinical picture supports a viscosupplementation approach. MPM determines the right option based on diagnosis, risk, expected benefit, and patient preference.
PRP, prolotherapy, and BMAC are regenerative or orthobiologic approaches. PRP uses platelet-rich plasma prepared from the patient’s blood. Prolotherapy uses an injected solution to stimulate a local tissue response in selected ligament, tendon, or joint-related targets. BMAC uses concentrated bone marrow aspirate in selected musculoskeletal contexts.
Hyaluronic acid is not the same as these treatments. It is a viscosupplement most commonly used for knee osteoarthritis. MPM compares these options carefully because the best treatment depends on whether pain is primarily arthritis-related, inflammatory, instability-related, tendon-related, or mixed.
Evidence and guideline recommendations for hyaluronic acid injections are mixed. Some patients report symptom improvement, while others have limited response. Some guidelines do not recommend routine use for symptomatic knee osteoarthritis, while other clinical settings may still consider viscosupplementation for selected patients after shared decision-making.
MPM does not present hyaluronic acid injections as universally appropriate or superior to steroid injections, PRP, prolotherapy, BMAC, physical therapy, or surgery. The decision depends on arthritis severity, prior care, risk profile, insurance coverage, patient goals, and informed discussion.
After treatment, patients may have soreness, swelling, warmth, stiffness, or a temporary flare. Many patients can walk after the injection, but activity modification may be recommended for a short period depending on the case. The number of injections depends on the product and treatment plan.
If the injection does not help, MPM reassesses whether knee osteoarthritis is the main pain source or whether another contributor is present. The next step may include rehabilitation, bracing, medication management, steroid injection, PRP, prolotherapy, BMAC, imaging review, or orthopedic referral.
Risks may include injection-site pain, swelling, warmth, stiffness, bruising, bleeding, infection, allergic reaction, post-injection flare, incomplete relief, temporary relief only, or persistent symptoms.
Patients should seek urgent evaluation for fever, spreading redness, severe swelling, hot swollen joint, sudden inability to bear weight, new weakness, new numbness, suspected infection, major trauma, calf swelling, shortness of breath, chest pain, or rapidly worsening symptoms.
For selected patients, hyaluronic acid viscosupplementation may be one part of a knee arthritis care plan. MPM’s role is to determine whether the diagnosis, mechanics, safety profile, and treatment goals support its use within a coordinated, medically responsible framework.
